The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,183.00
Bid: 1,181.00
Ask: 1,182.00
Change: 22.50 (1.94%)
Spread: 1.00 (0.085%)
Open: 1,167.50
High: 1,183.50
Low: 1,162.50
Prev. Close: 1,160.50
SGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

12 Mar 2020 18:18

RNS Number : 0148G
Sage Group PLC
12 March 2020
 

Transaction in own shares

The Sage Group plc ("Sage" or the "Company") today announces that on 12 March 2020 it purchased a total of 256,000 of its ordinary shares of 1 4/77 pence each, as further detailed below.

 

Per Ordinary Share

Average price paid

£5.7829

Highest price paid

£6.0040

Lowest price paid

£5.5460

 

These share purchases form part of the Company's share buy-back programme, details of which were announced on 12 March 2020.

In respect of this programme, which will operate until not later than 13 January 2021, Citigroup Global Markets Limited ("Citigroup") and Morgan Stanley International ("Morgan Stanley") will make trading decisions in relation to shares purchased independently of, and uninfluenced by Sage.

Any such share purchases will be effected within certain pre-set parameters, and in accordance with Sage's general authority to repurchase ordinary shares, Chapter 12 of the Listing Rules and those provisions of Market Abuse Regulation 596/2014/EU dealing with buy-back programmes.

The Company will hold the purchased shares in treasury, to be used to meet obligations arising from share option programmes or other allocations of shares to employees or directors.

Following the above transaction, the issued share capital of Sage consists 1,120,789,295 ordinary shares of 14/77 pence each, of which 29,397,899 ordinary shares of 14/77 pence each would be held in treasury. Therefore, the total exercisable voting rights in Sage will be 1,091,391,396.

The above figure 1,091,391,396 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Sage under the DTRs. In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), a schedule of individual trades by Citigroup is available using the following link:

http://www.rns-pdf.londonstockexchange.com/rns/0148G_1-2020-3-12.pdf

End

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSEAPDAFFLEEFA
Date   Source Headline
13th Feb 20236:16 pmRNSPublication of Final Terms
9th Feb 20239:32 amRNSDirector/PDMR Shareholding
7th Feb 20239:46 amRNSDirector/PDMR Shareholding
3rd Feb 202312:14 pmRNSDirector Declaration
2nd Feb 20233:31 pmRNSResult of AGM
2nd Feb 20239:57 amRNSDirector Declaration
31st Jan 20233:35 pmRNSSage: Publication of Base Prospectus
31st Jan 20233:00 pmRNSTotal Voting Rights
23rd Jan 20234:58 pmRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update for the 3 months ended 31 Dec 2022
30th Dec 202211:15 amRNSTotal Voting Rights
15th Dec 202211:21 amRNSDirector/PDMR Shareholding
8th Dec 20225:40 pmRNSDirector/PDMR Shareholding
8th Dec 20227:00 amRNSUpdate on financial reporting
7th Dec 20226:00 pmRNSDirector/PDMR Shareholding
7th Dec 202210:12 amRNSNotice of AGM
6th Dec 20226:13 pmRNSDirector/PDMR Shareholding
6th Dec 20225:23 pmRNSDirector/PDMR Shareholding
6th Dec 202210:25 amRNSBlock listing Interim Review
1st Dec 202211:03 amRNSAnnual Financial Report
30th Nov 20222:00 pmRNSTotal Voting Rights
24th Nov 202210:00 amRNSNon-executive Director Appointment
18th Nov 20229:13 amRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSResults for the year ended 30 September 2022
15th Nov 20227:00 amRNSNon-executive Director Appointment
31st Oct 20223:00 pmRNSTotal Voting Rights
30th Sep 202211:45 amRNSTotal Voting Rights
20th Sep 20227:00 amRNSInvestor and Analyst Event
31st Aug 20223:44 pmRNSTotal Voting Rights
30th Aug 20225:10 pmRNSSage completes Lockstep acquisition
24th Aug 20223:37 pmRNSDirector/PDMR Shareholding
18th Aug 202210:19 amRNSDirector/PDMR Shareholding
16th Aug 20227:00 amRNSSage to acquire Lockstep
2nd Aug 20227:00 amRNSTrading update for nine months ended 30 June 2022
29th Jul 20224:04 pmRNSTotal Voting Rights
22nd Jul 20229:02 amRNSDirectorate Change
30th Jun 20224:10 pmRNSTotal Voting Rights
24th Jun 20224:34 pmRNSDirector/PDMR Shareholding
16th Jun 20223:38 pmRNSDirector/PDMR Shareholding
8th Jun 20224:48 pmRNSDirector/PDMR Shareholding
8th Jun 20229:00 amRNSDirector Declaration
7th Jun 20222:53 pmRNSDirector/PDMR Shareholding
6th Jun 20222:00 pmRNSBlock listing Interim Review
31st May 20225:09 pmRNSTotal Voting Rights
25th May 20225:24 pmRNSDirector/PDMR Shareholding
19th May 20225:36 pmRNSDirector/PDMR Shareholding
19th May 20225:20 pmRNSDirector/PDMR Shareholding
13th May 20227:00 amRNSResults for the 6 months to 31 March 22 unaudited
29th Apr 20224:10 pmRNSTotal Voting Rights
31st Mar 20223:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.